[ad_1]
Walgreens, Walmart and CVS informed a federal appeals panel on Thursday that the reasoning at the back of an opioid abatement fund awarded to 2 Ohio counties, if extrapolated, would put them at the hook for almost $500 billion in public fitness prices national.
In a gap transient with the U.S. Court docket of Appeals for the 6th Circuit, the 3 pharmacies sought to overturn a 2021 jury verdict and next $650 million abatement award, to be paid over 15 years. The pharmacies’ attorneys contend U.S. District Pass judgement on Dan Polster of the Northern District of Ohio’s “unparalleled” abatement award, issued on Aug. 17, would impermissibly “fund a complete slate of presidency public-health techniques designed to deal with the large downstream fitness, social, and criminal-justice results of the opioid disaster for the following half-generation.”
[ad_2]
